恩扎鲁胺
医学
前列腺癌
醋酸阿比特龙酯
彭布罗利珠单抗
内科学
肿瘤科
队列
四分位间距
不利影响
临床终点
雄激素剥夺疗法
癌症
临床试验
雄激素受体
免疫疗法
作者
Evan Y. Yu,William R. Berry,Howard Gurney,Margitta Retz,Henry Jacob Conter,Brigitte Laguerre,Peter C.C. Fong,Cristiano Ferrario,Tilman Todenhöfer,Gwénaëlle Gravis,Josep M. Piulats,Urban Emmenegger,Neal D. Shore,Emanuela Romano,Loı̈c Mourey,Xin Tong Li,Christian Poehlein,Charles Schloss,Leonard J. Appleman,Johann S. de Bono
标识
DOI:10.1016/j.euo.2023.10.008
摘要
Limited responses have been observed in patients treated with enzalutamide after disease progression on abiraterone for metastatic castration-resistant prostate cancer (mCRPC), but androgen receptor signaling impacts T-cell function.
科研通智能强力驱动
Strongly Powered by AbleSci AI